Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus Vaccines
Researchers from Tarbiat Modares University, Department of Virology discuss findings in human papillomavirus vaccines
October 21st, 2008
New investigation results, 'Isolation and cloning of human papillomavirus 16 L1 gene from Iranian isolate,' are detailed in a study published in Saudi Medical Journal. "To isolate and construct cloning and expression vectors containing human papillomavirus (HPV16-L1) gene as target for application as recombinant vaccine. The study was performed in 2007 in Tarbiat Modares University, Tehran, Iran," investigators in Iran report. "Four genital specimens DNAs were amplified with the use of HPV type-specific primers based on HPV-16 L1, E6, and E7 genes. The polymerase chain reaction products were cloned into suitable cloning and expression vectors and were confirmed...
Source: Cancer Weekly (2008-10-21)
|
